Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
MesenFlow Technologies SARL logo — company profile

MesenFlow Technologies SARL

Founded 2016 Switzerland Plan-les-ouates, Switzerland 3 employees Grant Total: $10.00K Health Care

General Information

Company Name MesenFlow Technologies SARL
Founded Year 2016
Location Switzerland Plan-les-ouates, Switzerland
Employees 3
Industries Health Care
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with MesenFlow Technologies SARL. To contact MesenFlow Technologies SARL, visit mesenflow.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does MesenFlow Technologies SARL compare?

A PDF of MesenFlow Technologies SARL and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting MesenFlow Technologies SARL soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About MesenFlow Technologies SARL

MesenFlow Technologies SARL is a Swiss-based startup founded in 2016, focusing on accelerating drug and cosmetic development through innovative translational medicine techniques. Spearheaded by Dr. Paul Bradfield and Professor Beat Imhof, the company's platform utilizes 'animal-free' methodologies, including chronic disease tissue engineering and human disease tissue and blood, to develop high-throughput human "organoid" models. This technology, funded by a Fr.10.00K grant from Venture Kick in April 2017, has numerous applications in product safety analysis, inflammation, oncology, and toxicology. MesenFlow's 'One-Stop' service approach complements existing development strategies, expediting toxicity, efficacy, and mechanism-of-action screenings, thus potentially reducing attrition and costs in compound development. The company anticipates improving clinical trial success rates by providing relevant data derived from its translational technologies. MesenFlow Technologies' ambitious objective is to extend its impact across all facets of compound development and to revolutionize safety measures while reducing associated costs.

Business keywords: translational medicine, drug development, cosmetic development, toxicity assessment, inflammatory assessment, tissue engineering, organoid models, preclinical phase, oncology, clinical trials, translational technologies, compound development, safety assessment, cost reduction

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Fr.10.00K 1
Venture Kick
Venture Kick
25 Apr 2017
Non Equity Assistance Undisclosed 1
MassChallenge
MassChallenge
19 May 2016

MesenFlow Technologies SARL Alternatives & Competitors

View All Alternatives
MesenFlow Technologies SARL vs
Keen Eye Technologies
Keen Eye Technologies

AI platform elevates pathology for drug development and diagnostics, supporting all stages and organ...

Series A
AI, Biotechnology
MesenFlow Technologies SARL vs
OCEAN BIOMEDICAL
OCEAN BIOMEDICAL United States

Empowering great medical science.

Post-IPO Debt
12 employees
Biotechnology, Health Care
MesenFlow Technologies SARL vs
CytRx
CytRx

Driving Oncology Innovation with Advanced Chemotherapeutic Solutions

Post-IPO Equity
Biopharma, Biotechnology
View all alternatives

FAQ About MesenFlow Technologies SARL

MesenFlow Technologies has developed a platform for accelerated drug and cosmetic development, using a series of ‘animal-free’ translational medicine techniques. Our platform also has specific applications in product safety analysis, where sophisticated toxicity and inflammatory assessments are requ...
MesenFlow Technologies SARL was founded in 2016.
MesenFlow Technologies SARL is headquartered in Plan-les-ouates, Switzerland.
MesenFlow Technologies SARL operates in Health Care. Its work centres on translational medicine, drug development, cosmetic development and toxicity assessment.
MesenFlow Technologies SARL has approximately 3 employees.
MesenFlow Technologies SARL has completed 2 funding rounds, raising a total of $10.00K. The latest funding stage is Grant.
Top alternatives and competitors to MesenFlow Technologies SARL include Keen Eye Technologies, OCEAN BIOMEDICAL, CytRx, NeuCyte, OncXerna Therapeutics . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MesenFlow Technologies SARL and Keen Eye Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for MesenFlow Technologies SARL, https://bouncewatch.com/company/mesenflow-technologies-sarl, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout